Patients can achieve an optimal daily dose of 1800 mg with just 2 - 900 mg tablets1

A well-tolerated, once-daily
treatment for the management of
postherpetic neuralgia (PHN)12

450 mg, and 750 mg strengths also available.

References:

  1. GRALISE. Prescribing information. Almatica Pharma LLC; 2023.
  2. Irving GA, Sweeney M. Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia. J Pain Res. 2012;5:203-208.
Not actual patients.

Gabapentin is a controlled substance in several states. Contact local authorities for more information. Advise patients to take GRALISE only as prescribed.